Connexin-26 Is a Key Factor Mediating Gemcitabine Bystander Effect

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-10-0693
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search